GAP-f

The GAP-f Network is hosted by WHO and was created to address the gap in paediatric medicines through coordination and collaboration among key stakeholders

[GAP-f @GAP_f_Network]

Looking forward to seeing you join the webinar next week! There is still time to register at https://t.co/xANERzI4d6

[GAP-f @GAP_f_Network]

📢 Join the first 2026 #BetterMeds4Kids webinar from GAP-f on "Closing the Gap Between Policy and Practice: The Key Role of the Essential Medicine List for Children"
Learn about the 2025 EMLc updates & how the list can be adopted and adapted in #countries for better #access2meds in #children.

📅 25 Mar 2026
🕑 14:00 CEST
🔗 Register: https://t.co/srnu0xqkRA
#PaediatricMedicines #Bettermeds4kids

[GAP-f @GAP_f_Network]

📢 Join the first 2026 #BetterMeds4Kids webinar from GAP-f on "Closing the Gap Between Policy and Practice: The Key Role of the Essential Medicine List for Children"
Learn about the 2025 EMLc updates & how the list can be adopted and adapted in #countries for better #access2meds in #children.

📅 25 Mar 2026
🕑 14:00 CEST
🔗 Register: https://t.co/srnu0xqkRA
#PaediatricMedicines #Bettermeds4kids

[GAP-f @GAP_f_Network]

📣Join our GAP-f team @WHO!
We’re looking for someone passionate about #access to paediatric medicines and to help strengthen the paediatric medicines ecosystem in the ASEAN region.
🔍Learn more & apply: https://t.co/N1p1MW91pO
🗓 Deadline: 9 Feb 2026

#BetterMeds4kids

[GAP-f @GAP_f_Network]

🌍 World Children’s Day reminds us why we do this work.

Grateful to all our partners who move with us toward one goal: better #medicines for every #child.

🎥 Sharing a short video that captures our “why.”
https://t.co/AFeGuMvQYQ

#WorldChildrensDay #BetterMeds4Kids #GAPf #WHO

[GAP-f @GAP_f_Network]

In the run-up to #WorldChildrensDay, the first-ever PADO for #Malaria report is now live!

This @WHO -led process sets priority actions to accelerate development & access to optimal malaria treatments for children.

It also aligns with ongoing WHO work — including the review of artemether–lumefantrine for neonates (a PADO-priority product!) for potential inclusion in @WHO guidelines.

👉 Read the report: https://t.co/UkSjp6oese

[GAP-f @GAP_f_Network]

📢Reminder: Call for consultation: Draft Target Product Profile for a paediatric formulation of Hydroxyurea! @WHO is seeking feedback on hydroxyurea draft TPPs.
The draft TPP and the feedback forms can be found here 👉https://t.co/ClgtPQhg1X
📅 Deadline for the call is 7 November 2025

[GAP-f @GAP_f_Network]

📢Calling industry partners to be part of the global effort to accelerate better medicines for children.

🌏GAP-f works through an ecosystem approach to close gaps in paediatric medicines. The private sector is a key partner in accelerating innovation and access for #children.

👉 Join the Industry GAP-f mailing list: https://t.co/sNdk49mPho
👉 Register for our next Private Sector Dialogue on November 11 https://t.co/01nQeiYsH4

#BetterMeds4Kids #GlobalHealth #AccessToMedicines

[GAP-f @GAP_f_Network]

📢Delighted to amplify the new #WHO Model List of Essential Medicines for Children 📘

GAP-f contributed by assessing age appropriateness of approximately 290 #medicines using the #QTPP tool to inform removal of 92 outdated formulations & addition of 163 new ones- a big step for contributing towards #Bettermeds4kids🌍👶

Find out more here ⬇️
🔗 EML: https://t.co/dc61zhpHQe
🔗QTPP: https://t.co/ibj9MBBTfI

[World Health Organization (WHO) @WHO]

Many essential medicines are not designed for children.

That means crushed pills, inaccurate doses, and bitter tastes that make treatment hard to take.

@GAP_f_Network is working to close this gap.

🔗https://t.co/GoJVFjUdJI

#HealthForAll

[World Health Organization (WHO) @WHO]

Too many children are given medicines that were never properly tested for them.

That means imprecise dosing—and real risks.

💡 The @GAP_f_Network is changing the game.

They’re fast-tracking the development of medicines made for children—not just scaled-down versions of adult treatments.

Check it out: https://t.co/V5VtRLQzfl

[World Health Organization (WHO) @WHO]

The @GAP_f_Network is improving access to medicines designed for children — but it can’t do it alone.

It takes a village.

Ensuring children get access to the medicines they need means working hand-in-hand with communities, countries, regulators, funders, private sector entities, and health care professionals.

[World Health Organization (WHO) @WHO]

The new strategy to invest in children’s health by @GAP_f_Network sets a clear direction for 2030:
🔹 Focus on the most urgent diseases
🔹 Speed up access to key medicines
🔹 Strengthen the paediatric medicines ecosystem

A $40M investment means lives saved with no time lost.

[GAP-f @GAP_f_Network]

📢First-Ever PADO for #RSV Report Released!

Led by @WHO, it sets key R&D + access priorities to prevent & treat #RSV in kids over the next 3–10 yrs. Find out more👇https://t.co/hR3zffDsUn
#Bettermeds4kids

[GAP-f @GAP_f_Network]

Looking forward to welcoming you all to the launch today. There is still time to register here https://t.co/KnwkPEl07k

[GAP-f @GAP_f_Network]

📢 Join us for the next #BetterMeds4Kids webinar!

🗓️ 8 July 2025 | 🕑 14:00–15:00 CEST
🌍 Topic: Optimizing tools for the prevention and treatment of RSV disease in children: Priorities and the Path Forward
📄 Featuring the launch of GAP-f’s PADO report on RSV

🔗 Register now: https://t.co/I0HaifCjGy

#Bettermeds4kids

[GAP-f @GAP_f_Network]

📢 Join us for the next #BetterMeds4Kids webinar!

🗓️ 8 July 2025 | 🕑 14:00–15:00 CEST
🌍 Topic: Optimizing tools for the prevention and treatment of RSV disease in children: Priorities and the Path Forward
📄 Featuring the launch of GAP-f’s PADO report on RSV

🔗 Register now: https://t.co/I0HaifCjGy

#Bettermeds4kids

[GAP-f @GAP_f_Network]

📣GAP-f has just launched its 2025–2030 Strategy with a bold goal:
✅ 10 diseases
✅ 10 medicines
✅ 10 countries
All by 2030.
Because every child deserves timely access to the medicines they need.
📄 Learn more 👉WHO launches global accelerator for Paediatric Formulations Strategic Roadmap 2025–2030

[GAP-f @GAP_f_Network]

🔍 New study reveals critical gaps in paediatric medicines on national essential medicines lists—especially in LMICs.

Our children’s health is at risk. This is why our collective work is more important than ever.

🚨 It's time for equitable access to #BetterMeds4Kids.

📖 Read more here👇 https://t.co/oJtNNpmWjf

[GAP-f @GAP_f_Network]

📢Join us at the 78th World Health Assembly for a high-level side event on advancing access to paediatric medicines!
📅 20 May 2025,
🕰️18:30–20:30 CET at Jardin de Penthes, Geneva
🚀Let's strengthen the global ecosystem for #children's #health together!
🔗https://t.co/7LBX26x1sG
#WHA78 #BetterMeds4Kids #GlobalHealth

[GAP-f @GAP_f_Network]

📢Just published in The Lancet Child & Adolescent Health!

"Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas"

💊 A step toward simplifying and standardising paediatric treatment globally.

📄 Read: https://t.co/s6TL0f33yC
#ChildHealth #Bettermeds4kids #GAPf

[GAP-f @GAP_f_Network]

📢 The Target Product Profiles for priority #paediatric formulations of azithromycin & nitrofurantoin are now available! 📄👇
🔗 https://t.co/XtPYv0v1Zm
Interested #Manufacturers are invited to submit an EOI for product evaluation to #WHO
🔗 Please see https://t.co/SMEgWzf4Z6
#Bettermeds4kids #Antibiotics